Prognostic analysis of aberrant somatic hypermutation of RhoH gene in diffuse large B cell lymphoma [14]

Leukemia

Volumn 21, Issue 8, 2007, Pages 1846-1847

  Hiraga, J ^a   Katsumi, A ^a   Iwasaki, T ^a   Abe, A ^a   Kiyoi, H ^a   Matsushita, T ^a   Kinoshita, T ^a   Naoe, T ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; RHOH PROTEIN; UNCLASSIFIED DRUG;

ADULT; B CELL LYMPHOMA; CANCER GENETICS; CANCER STAGING; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GENE AMPLIFICATION; GENE DELETION; GENE INSERTION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SCREENING; HUMAN; LARGE CELL LYMPHOMA; LETTER; LYMPH NODE; MALE; MOLECULAR CLONING; NUCLEIC ACID BASE SUBSTITUTION; OVERALL SURVIVAL; POINT MUTATION; PRIORITY JOURNAL; SOMATIC CELL GENETICS; SOMATIC HYPERMUTATION; SURVIVAL RATE; TEMPERATURE;

EID: 34447645995     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404717     Document Type: Letter

References (8)

1. Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti RS, Kuppers R et al. Hypermutation of multiple protooncogenes in B-cell diffuse large-cell lymphomas. Nature 2001; 412: 341-346.
2. Gu Y, Jasti AC, Jansen M, Siefring JE. RhoH, a hematopoietic-specific Rho GTPase, regulates proliferation, survival, migration, and engraftment of hematopoietic progenitor cells. Blood 2005; 105 1467-1475.
3. Cherry LK, Li X, Schwab P, Lim B, Klickstein LB. RhoH is required to maintain the integrin LFA-1 in a nonadhesive state on lymphocytes. Nat Immunol 2004; 5: 961-967.
4. Li X, Bu X, Lu B, Avraham H, Flavell RA, Lim B. The hematopoiesis-specific GTP-binding protein RhoH is GTPase deficient and modulates activities of other Rho GTPases by an inhibitory function. Mol Cell Biol 2002; 22: 1158-1171.
5. Liso A, Capello D, Marafioti T, Tiacci E, Cerri M, Distler V et al. Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. Blood 2006; 108: 1013-1020.
6. Dijkman R, Tensen CP, Buettner M, Niedobitek G, Willemze R, Vermeer MH. Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID. Blood 2006; 107: 4926-4929.
7. Libra M, Capello D, Gloghini A, Laura P, Berra E, Cerri M et al. Analysis of aberrant somatic hypermutation (SHM) in non-Hodgkin's lymphomas of patients with chronic HCV infection. J Pathol 2005; 206: 87-91.
8. Kiyoi H, Yamaji S, Kojima S, Naoe T. JAK3 mutations occur in acute megakaryoblastic leukemia both in Down syndrome children and non-Down syndrome adults. Leukemia 2007; 21: 574-576.